Diagnostic and Prognostic Value of HABP2 As a Novel Biomarker for Endometrial Cancer

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Nov 26

PMID 33241013

Citations 3

Authors

Ying Jiang

Jinfeng Li

Cuiqin Sang

Guangming Cao

Shuzhen Wang

Affiliations

Soon will be listed here.

Abstract

Background: Endometrial cancer is the fifth most common malignant disorder in women, with its incidence increasing. A biomarker with diagnostic and prognostic value remains to be found. The HABP2 protein, or Factor VII-activating protease, encodes a hyaluronic acid-binding protein.

Methods: Patient data including clinical characteristics and RNAseq information of HABP2 was obtained from The Cancer Genome Atlas (TCGA), and analyzed by R statistic packages. A total of 370 women with endometrial cancer were enrolled in the study. To study the diagnostic value of HABP2 in patients with endometrial cancer, receiver operating characteristic (ROC) curves were plotted by the pROC package. To study the prognostic value of HABP2 in patients with endometrial cancer, the survival package in R was used and the Cox model was established.

Results: HABP2 expression was lower in endometrial cancer compared with normal endometrial tissues. HABP2 showed moderate diagnostic value for endometrial cancer, with HBP2 expression associated with vital status, histologic grade, and residual tumor. HABP2 was an independent prognostic factor, with low HABP2 expression indicating a better overall survival.

Conclusions: HABP2 has diagnostic and prognostic value and maybe a novel biomarker for endometrial cancer.

Citing Articles

Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer.

Rowlands C, Folberg A, Beickman Z, Devor E, Leslie K, Givens B Small. 2023; 20(41):e2300096.

PMID: 37312613 PMC: 10716380. DOI: 10.1002/smll.202300096.

Role of Hyaluronic Acid in Selected Malignant Neoplasms in Women.

Markowska A, Antoszczak M, Markowska J, Huczynski A Biomedicines. 2023; 11(2).

PMID: 36830841 PMC: 9953106. DOI: 10.3390/biomedicines11020304.

Exploration of Potential Biomarkers and Immune Landscape for Hepatoblastoma: Evidence from Machine Learning Algorithm.

Zhou P, Gao S, Hu B Evid Based Complement Alternat Med. 2022; 2022:2417134.

PMID: 35958911 PMC: 9357682. DOI: 10.1155/2022/2417134.

References

Jiao Y, Fu Z, Li Y, Zhang W, Liu Y . Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer. PLoS One. 2019; 14(1):e0211291. PMC: 6351057. DOI: 10.1371/journal.pone.0211291. View

Cantara S, Marzocchi C, Castagna M, Pacini F . HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series. J Endocrinol Invest. 2016; 40(5):557-560. DOI: 10.1007/s40618-016-0583-9. View

Yang H, Meeker A, Guido R, Gunter M, Huang G, Luhn P . PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors. Cancer Causes Control. 2015; 26(12):1729-36. PMC: 4628559. DOI: 10.1007/s10552-015-0666-5. View

Jiao Y, Li Y, Fu Z, Hou L, Chen Q, Cai Y . Expression as a Prognostic Biomarker for Liver Cancer Patients. Dis Markers. 2019; 2019:9037131. PMC: 6855184. DOI: 10.1155/2019/9037131. View

Kanse S, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner K . Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thromb Haemost. 2008; 99(2):286-9. DOI: 10.1160/TH07-10-0640. View

Altmae S, Kallak T, Friden B, Stavreus-Evers A . Variation in hyaluronan-binding protein 2 (HABP2) promoter region is associated with unexplained female infertility. Reprod Sci. 2010; 18(5):485-92. DOI: 10.1177/1933719110388849. View

Cai H, Jiao Y, Li Y, Yang Z, He M, Liu Y . Low CYP24A1 mRNA expression and its role in prognosis of breast cancer. Sci Rep. 2019; 9(1):13714. PMC: 6757028. DOI: 10.1038/s41598-019-50214-z. View

Sidelmann J, Vitzthum F, Funding E, Munster A, Gram J, Jespersen J . Factor VII-activating protease in patients with acute deep venous thrombosis. Thromb Res. 2008; 122(6):848-53. DOI: 10.1016/j.thromres.2008.02.002. View

Zhao Y, Jiao Y, Li Y, Fu Z, Yang Z, He M . Elevated high mobility group A2 expression in liver cancer predicts poor patient survival. Rev Esp Enferm Dig. 2019; 112(1):27-33. DOI: 10.17235/reed.2019.6365/2019. View

10.

Zhou L, Jiao Y, Chen H, Kang L, Yang Q, Li J . Differentially expressed long noncoding RNAs and regulatory mechanism of LINC02407 in human gastric adenocarcinoma. World J Gastroenterol. 2019; 25(39):5973-5990. PMC: 6815795. DOI: 10.3748/wjg.v25.i39.5973. View

11.

Corrado G, Bruni S, Vizza E . Robotic surgery in early-stage endometrial cancer. Transl Cancer Res. 2022; 8(Suppl 6):S573-S576. PMC: 8797806. DOI: 10.21037/tcr.2019.08.27. View

12.

Kannemeier C, Al-Fakhri N, Preissner K, Kanse S . Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. FASEB J. 2004; 18(6):728-30. DOI: 10.1096/fj.03-0898fje. View

13.

Fu Z, Jiao Y, Li Y, Ke J, Xu Y, Jia B . PES1 In Liver Cancer: A Prognostic Biomarker With Tumorigenic Roles. Cancer Manag Res. 2019; 11:9641-9653. PMC: 6861535. DOI: 10.2147/CMAR.S226471. View

14.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

15.

Colombo C, Muzza M, Proverbio M, Ercoli G, Perrino M, Cirello V . Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review. Clin Endocrinol (Oxf). 2017; 86(6):837-844. DOI: 10.1111/cen.13316. View

16.

Alzahrani A, Murugan A, Qasem E, Al-Hindi H . HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population. Thyroid. 2016; 26(5):667-71. DOI: 10.1089/thy.2015.0537. View

17.

Merritt M, Strickler H, Einstein M, Yang H, Sherman M, Wentzensen N . Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control. 2016; 27(6):737-48. PMC: 4870288. DOI: 10.1007/s10552-016-0751-4. View

18.

Lee T, Jung J, Kim J, Park N, Song Y, Kang S . Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol. 2006; 104(1):52-7. DOI: 10.1016/j.ygyno.2006.07.003. View

19.

Weeks A, Wilson S, Ward L, Goldblatt J, Hui J, Walsh J . HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer. BMC Med Genet. 2016; 17(1):60. PMC: 4988026. DOI: 10.1186/s12881-016-0323-1. View

20.

Li Y, Jiao Y, Fu Z, Luo Z, Su J, Li Y . High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma. Cancer Manag Res. 2019; 11:2795-2802. PMC: 6497481. DOI: 10.2147/CMAR.S196655. View